Latest / Markets & Money News Today | 2 Min News | THE DAILY NOW!
J&J's Promising New Prostate Cancer Drug | Markets & Money News
Johnson & Johnson’s experimental prostate cancer drug, JNJ-6143, has shown promising results in an early-stage trial, with tumors disappearing or shrinking in several patients. This breakthrough follows J&J’s $3.05 billion acquisition of Halda Therapeutics. In the trial, 77% of participants experienced at least a 50% drop in PSA levels, while 69% with measurable tumors had complete or partial responses. Despite some patients experiencing side effects like nausea and elevated cholesterol, these
www.TheDailyNewsNow.com
This is an automated, high-level news summary based on public reporting and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.